Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

Contemporary Management of Risk Factors in Coronary Artery Disease (Part 1)

Author(s): Dimitris Tousoulis and Panagiotis Theofilis

Volume 29, Issue 23, 2023

Published on: 30 August, 2023

Page: [1801 - 1801] Pages: 1

DOI: 10.2174/138161282923230830161312

Price: $65

Next »
[1]
Delialis D, Dimopoulou M A, Papaioannou M, et al. PCSK9 inhibition in atherosclerotic cardiovascular disease. Curr Pharm Des 2023; 29(23): 1802-24.
[2]
Theofilis P, Oikonomou E, Sagris M, Papageorgiou N, Tsioufis K, Tousoulis D. Novel concepts in the management of angina in coronary artery disease. Curr Pharm Des 2023; 29(23): 1825-34.
[3]
Dimitroglou Y, Aggeli C, Theofilis P, et al. Lipoprotein(a) as a predictive biomarker and therapeutic target for acute coronary syndromes. Curr Pharm Des 2023; 29(23): 1835-43.
[4]
Oikonomou E, Xenou M, Zakynthinos G E, et al. Novel approaches to the management of diabetes mellitus in patients with coronary artery disease. Curr Pharm Des 2023; 29(23): 1844-62.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy